How should I treat?

How should I treat severe paravalvular leakage after TAVI?

EuroIntervention 2013;9:650-653. DOI: 10.4244/EIJV9I5A104

Markus Reinthaler1*, MD; Klaus Empen1, MD; Mathias Busch1, MD; Raik Könemann1, MA; Hüseyin Ince2, MD; Stephan B. Felix1, MD

1. Department of Cardiology, Ernst-Moritz-Arndt University, Greifswald, Germany; 2. Department of Cardiology, University of Rostock, Rostock, Germany

The case presented is of severe paravalvular aortic regurgitation (AR) related to low malpositioning of a 26 mm Medtronic CoreValve (MCV) bioprosthesis performed by a transaortic approach. The prosthesis was sized by two-di

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Share on Facebook Share on Twitter Share on Linkedin

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers